Literature DB >> 26741528

Red alert: labile heme is an alarmin.

Miguel P Soares1, Marcelo T Bozza2.   

Abstract

Alarmins are a heterogeneous group of endogenous molecules that signal cellular damage when sensed extracellularly. Heme is an endogenous molecule that acts as a prosthetic group of hemoproteins, such as hemoglobin and myoglobin. When released from damaged red blood cells or muscle cells, oxidized hemoglobin and myoglobin release their prosthetic heme groups, respectively. This generates labile heme, which is sensed by pattern recognition receptors (PRR) expressed by innate immune cells and possibly regulatory T cells (TREG). The ensuing adaptive response, which alerts for the occurrence of red blood cell or muscle cell damage, regulates the pathologic outcome of hemolysis or rhabdomyolysis, respectively. In conclusion, we propose that labile heme is an alarmin.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26741528     DOI: 10.1016/j.coi.2015.11.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  53 in total

1.  Stressed erythrophagocytosis induces immunosuppression during sepsis through heme-mediated STAT1 dysregulation.

Authors:  Tolani F Olonisakin; Tomeka Suber; Shekina Gonzalez-Ferrer; Zeyu Xiong; Hernán F Peñaloza; Rick van der Geest; Yuting Xiong; David O Osei-Hwedieh; Jesús Tejero; Matthew R Rosengart; Wendy M Mars; Daria Van Tyne; Andreas Perlegas; Samuel Brashears; Daniel B Kim-Shapiro; Mark T Gladwin; Michael A Bachman; Eldad A Hod; Claudette St Croix; Yulia Y Tyurina; Valerian E Kagan; Rama K Mallampalli; Anuradha Ray; Prabir Ray; Janet S Lee
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

2.  Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease.

Authors:  Raisa Balbuena-Merle; Susanna A Curtis; Lesley Devine; David R Gibb; Matthew S Karafin; Chance John Luckey; Christopher A Tormey; Alexa J Siddon; John D Roberts; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-07-29       Impact factor: 3.157

Review 3.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 4.  Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses.

Authors:  B M Matta; D K Reichenbach; B R Blazar; H R Turnquist
Journal:  Am J Transplant       Date:  2016-07-12       Impact factor: 8.086

5.  Free heme regulates placenta growth factor through NRF2-antioxidant response signaling.

Authors:  Maria G Kapetanaki; Oluwabukola T Gbotosho; Deva Sharma; Frances Weidert; Solomon F Ofori-Acquah; Gregory J Kato
Journal:  Free Radic Biol Med       Date:  2019-08-10       Impact factor: 7.376

Review 6.  Deferoxamine therapy reduces brain hemin accumulation after intracerebral hemorrhage in piglets.

Authors:  Shengli Hu; Ya Hua; Richard F Keep; Hua Feng; Guohua Xi
Journal:  Exp Neurol       Date:  2019-05-10       Impact factor: 5.330

Review 7.  Innate Nutritional Immunity.

Authors:  Gabriel Núñez; Kei Sakamoto; Miguel P Soares
Journal:  J Immunol       Date:  2018-07-01       Impact factor: 5.422

8.  Protein aggregation as a cellular response to oxidative stress induced by heme and iron.

Authors:  Luiz R C Vasconcellos; Fabianno F Dutra; Mariana S Siqueira; Heitor A Paula-Neto; Jennifer Dahan; Ellen Kiarely; Leticia A M Carneiro; Marcelo T Bozza; Leonardo H Travassos
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 9.  Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

Authors:  Leo E Otterbein; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2016-06-10       Impact factor: 17.367

Review 10.  Breaking the law: unconventional strategies for antibody diversification.

Authors:  Alexia Kanyavuz; Annaelle Marey-Jarossay; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.